Indaptus Therapeutics, Inc. (INDP)
$2.51+5.91%Close
SELLCRISIS · day 9
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $4M
- Beta
- 1.17
- P/E (TTM)
- -0.37
- Short % float
- 57.68%
- Days to cover
- 1.0
- SI change
- -10.3%
- 1W
- +5.46%
- 1M
- -1.95%
- vs SPY 1W
- +4.30%
- vs SPY 1M
- -4.95%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on INDP?
- LOPJLB’s latest quantitative signal on Indaptus Therapeutics, Inc. (INDP) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is INDP in?
- Indaptus Therapeutics, Inc. (INDP) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Indaptus Therapeutics, Inc. (INDP) do?
- Indaptus Therapeutics, Inc. is a biotechnology company operating in the pre-clinical phase, dedicated to developing a range of immunotherapeutic products for the treatment of both cancer and viral infections. The firm's lead investigational compound, Decoy20, is currently progressing through Phase I clinical trials. This candidate is being evaluated for its capacity to elicit lasting therapeuti…